MYRIAD GENETICS, INC. Cash and Cash Equivalents
MYRIAD GENETICS, INC. (MYGN) had Cash and Cash Equivalents of $115.20 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-07-31
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $115.20M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $124.40M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $149.60M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $145.40M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $115.20M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $124.40M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $149.60M 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $145.40M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $74.40M 10-Q · filed 2026-07-31 | |
| 2025-03-31 | $91.80M 10-Q · filed 2026-05-06 | |
| 2024-12-31 | $102.40M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $99.90M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $92.40M 10-Q · filed 2025-08-06 | |
| 2024-03-31 | $96.90M 10-Q · filed 2025-05-07 | |
| 2023-12-31 | $132.10M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $76.00M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $102.80M 10-Q · filed 2024-08-07 | |
| 2023-03-31 | $53.60M 10-Q · filed 2024-05-08 | |
| 2022-12-31 | $56.90M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $108.70M 10-Q · filed 2023-11-07 | $110.70M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $104.20M 10-Q · filed 2023-08-04 | $105.20M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $164.20M 10-Q · filed 2023-05-04 | $165.20M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $257.40M 10-K · filed 2024-02-28 | $258.40M 10-K · filed 2022-02-25 |
| 2021-09-30 | $295.20M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $118.40M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $148.90M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $117.00M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $118.30M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $163.70M 10-K · filed 2023-03-01 | |
| 2020-03-31 | $121.00M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $81.20M 10-Q · filed 2020-02-07 | |
| 2019-09-30 | $89.90M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $93.20M 10-KT · filed 2021-03-16 | |
| 2019-03-31 | $84.90M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $90.60M 10-Q · filed 2019-02-06 | |
| 2018-09-30 | $93.30M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $110.90M 10-K · filed 2019-08-13 | |
| 2018-03-31 | $97.40M 10-Q · filed 2019-05-08 | |
| 2017-12-31 | $88.70M 10-Q · filed 2019-02-06 | |
| 2017-09-30 | $87.90M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $102.40M 10-K · filed 2019-08-13 | |
| 2017-03-31 | $123.80M 10-Q · filed 2018-05-09 | |
| 2016-12-31 | $108.00M 10-Q · filed 2018-02-07 | $108.10M 10-Q · filed 2017-02-08 |
| 2016-09-30 | $86.90M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $68.50M 10-K · filed 2019-08-13 | |
| 2016-03-31 | $120.50M 10-Q · filed 2017-05-03 | |
| 2015-12-31 | $134.70M 10-Q · filed 2017-02-08 | |
| 2015-09-30 | $87.40M 10-Q · filed 2016-11-02 | |
| 2015-06-30 | $64.10M 10-K · filed 2018-08-24 | |
| 2015-03-31 | $55.20M 10-Q · filed 2016-05-04 | $55.21M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $59.70M 10-Q · filed 2016-02-03 | $59.71M 10-Q · filed 2015-02-04 |
| 2014-09-30 | $69.80M 10-Q · filed 2015-11-04 | $69.80M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $64.80M 10-K · filed 2017-08-09 | $64.82M 10-K · filed 2014-08-13 |
| 2014-03-31 | $85.80M 10-Q · filed 2015-05-06 | |
| 2013-12-31 | $71.60M 10-Q · filed 2015-02-04 | |
| 2013-09-30 | $84.99M 10-Q · filed 2014-11-05 | |
| 2013-06-30 | $104.10M 10-K · filed 2016-08-10 | $104.07M 10-K · filed 2013-08-14 |
| 2013-03-31 | $112.32M 10-Q · filed 2014-05-07 | |
| 2012-12-31 | $68.42M 10-Q · filed 2014-02-05 | |
| 2012-09-30 | $95.58M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $86.40M 10-K · filed 2015-08-12 | $86.35M 10-K · filed 2012-08-15 |
| 2012-03-31 | $104.85M 10-Q · filed 2013-05-08 | |
| 2011-12-31 | $108.85M 10-Q · filed 2013-02-06 | |
| 2011-09-30 | $62.68M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $52.68M 10-K · filed 2014-08-13 | |
| 2011-03-31 | $67.38M 10-Q · filed 2012-05-02 | |
| 2010-12-31 | $67.67M 10-Q · filed 2012-02-01 | |
| 2010-09-30 | $123.31M 10-Q · filed 2011-11-02 | |
| 2010-06-30 | $92.84M 10-K · filed 2013-08-14 | |
| 2010-03-31 | $102.15M 10-Q · filed 2011-05-04 | |
| 2009-12-31 | $60.43M 10-Q · filed 2011-02-01 | |
| 2009-09-30 | $91.20M 10-Q · filed 2010-11-03 | |
| 2009-06-30 | $63.51M 10-K · filed 2012-08-15 | |
| 2008-06-30 | $237.73M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |